← All reports

Pfizer and ASKA Pharma are collaborating to promote the RSV vaccine Abrysvo in Japan.

GeneralMar 10, 2026score 0.172 posts · 0 replies across 1 instances
The thread discusses Pfizer and ASKA Pharma's plan to co-promote the RSV vaccine Abrysvo in Japan, highlighting a collaboration in the pharmaceutical sector. This collaboration is significant as it involves a major pharmaceutical company and a Japanese partner, potentially impacting public health and vaccine accessibility.

Claims

Pfizer and ASKA Pharma are collaborating to promote the RSV vaccine Abrysvo in Japan.
Parent: Pharmaceutical IndustryEntity: PfizerSub-entity: RSV vaccine AbrysvoImpact: positiveDate: Mar 10, 2026Target: Pfizer and ASKA Pharma's collaboration to promote the RSV vaccine Abrysvo in Japan

Source posts

@[email protected]
Pfizer, ASKA Pharma to co-promote RSV vaccine Abrysvo in Japan https://www.byteseu.com/1860756/ #Abrysvo #ASKAPharmaceutical #Japan #Pfizer #rsv
0 boosts · 0 favs · 0 replies · Mar 10, 2026
#abrysvo#askapharmaceutical#japan#pfizer#rsv
@[email protected]
https://www.europesays.com/2835207/ Pfizer, ASKA Pharma to co-promote RSV vaccine Abrysvo in Japan #Abrysvo #ASKAPharmaceutical #japan #Pfizer #rsv
0 boosts · 0 favs · 0 replies · Mar 10, 2026
#abrysvo#askapharmaceutical#japan#pfizer#rsv